undefined(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593

0.000

+0.000

--

最高0.000	最低0.000	成交量0.00
今开0.000	昨收0.000	日振幅0.00%
总市值0.00	流通市值0.00	总股本0.00
成交额0.00	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","latestPrice":0,"timestamp":0,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatusCode":0,"change":0,"open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"adr":0,"adjPreClose":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2485245806","title":"创新药子公司二闯IPO 四环医药“减负”","url":"https://stock-news.laohu8.com/highlight/detail?id=2485245806","media":"贝果财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485245806?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:06","pubTimestamp":1732287960,"startTime":"0","endTime":"0","summary":"取而代之的是，四环医药方面认为分拆“亦可以增强轩竹生物的公司治理及四环医药的营运管理能力”。轩竹生物由四环医药于2018年9月设立，通过整合四环医药创新药研发管线成为独立运营的创新药企业。截至11月12日，四环医药已支付约2.1亿元。医美业务仍需投入两次分拆轩竹生物上市，四环医药意在“腾笼换鸟”。在推动轩竹生物科创板IPO时，四环医药在公告中表示，完成分拆能帮助公司及子公司进一步向医美业务聚焦和转型发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-22/doc-incwyyts3350167.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-22/doc-incwyyts3350167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1515","159992","BK1161","BK1574","06978","00460","BK1593","BK1600"],"gpt_icon":0},{"id":"2485533132","title":"复星医药推进复宏汉霖私有化 交易审批存不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2485533132","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485533132?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:45","pubTimestamp":1732272342,"startTime":"0","endTime":"0","summary":"财中社11月22日电复星医药（600196/02196）发布关于对控股子公司复宏汉霖生物技术股份有限公司实施吸收合并及私有化的进展公告。根据公告，公司董事会于2024年6月24日及8月23日批准了对复宏汉霖的私有化方案，控股子公司复星新药将以现金及/或换股方式收购并注销复宏汉霖的全部股份，完成后复宏汉霖的法人主体将予以注销，所有资产、负债及权益将由复星新药承继。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411223248380674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02196","BK1593","02696","BK1191","BK1515","BK1161"],"gpt_icon":0},{"id":"2485237822","title":"昊海生物科技(06826)11月22日斥资55.21万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485237822","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485237822?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:08","pubTimestamp":1732270127,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2024年11月22日，该公司斥资55.21万港元回购2万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"gpt_icon":0},{"id":"2485302142","title":"复星医药子公司健嘉康复股权激励计划进展显著，关联交易引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2485302142","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485302142?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:05","pubTimestamp":1732269924,"startTime":"0","endTime":"0","summary":"财中社11月22日电复星医药（600196/02196）发布关于控股子公司健嘉康复股权激励计划实施进展暨关联交易的公告。公告指出，健嘉康复于2023年9月14日批准的股权激励计划中，新增发行注册资本共计7500万元，约占增发后注册资本总额的20%。截至本公告日，计划已完成两次跟投授予和两次期权授予，涉及金额分别为3500万元和2067万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411223248357297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1191","BK1593","02196"],"gpt_icon":0},{"id":"2485237899","title":"卓珈控股(01827)发盈警 预计中期股东应占估计亏损约50万港元至150万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485237899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485237899?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:04","pubTimestamp":1732269874,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卓珈控股(01827)发布公告，集团预期于截至2024年9月30日止六个月将取得公司权益持有人应占估计亏损约50万港元至150万港元，而2023年同期则取得1305万港元的亏损。该减少亏损乃主要由于营运效率的提升和有效的成本控制措施。该变动乃由于以下方面：(i)其他费用的减少，特别是由于提高运营效率而导致行政成本的减少以及由于实施更具针对性和有效性营销策略而导致营销费用的减少;以及(ii)通过改善营运系统令员工成本能更有效地运用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1215","BK1593","01827"],"gpt_icon":0},{"id":"2485233339","title":"昊海生物科技11月22日遭主力抛售268万元 环比增加300.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233339","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233339?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:16","pubTimestamp":1732263403,"startTime":"0","endTime":"0","summary":"11月22日, 昊海生物科技股价跌4.59%，报收27.00元，成交金额948万元，换手率0.86%，振幅5.30%，量比1.38。昊海生物科技今日主力资金净流出268万元，上一交易日主力净流出67万元，今日环比增加300.00%。该股近5个交易日下跌6.90%，主力资金累计净流出425万元；近20日主力资金累计净流出1664万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161738a24d6602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161738a24d6602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","06826"],"gpt_icon":0},{"id":"2485679235","title":"四环医药11月22日遭主力抛售356万元 环比增加2125.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485679235","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485679235?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:15","pubTimestamp":1732263318,"startTime":"0","endTime":"0","summary":"11月22日, 四环医药股价跌5.71%，报收0.66元，成交金额1184万元，换手率0.19%，振幅8.57%，量比1.13。四环医药今日主力资金净流出356万元，上一交易日主力净流出16万元，今日环比增加2125.00%。该股近5个交易日下跌1.49%，主力资金累计净流出300万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出3106万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161537a24d64b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161537a24d64b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1191","BK1593","BK1600","BK1515"],"gpt_icon":0},{"id":"2485806982","title":"中缅边贸往来中的人民币国际化问题——基于云南省瑞丽市的调查研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2485806982","media":"张明宏观金融研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485806982?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:26","pubTimestamp":1732260415,"startTime":"0","endTime":"0","summary":"注：本文发表于《财经智库》2024年第5期，转载请务必注明出处。文中配图摄于瑞丽国门。内容摘要：促进周边国家跨境往来中人民币的使用是稳慎扎实推进人民币国际化的关键一环。为深入了解中缅边贸往来中人民币国际化的真实现状与难点障碍，作者选择云南省瑞丽市作为调研地，通过对瑞丽市政府部门、金融机构、代表性边贸企业...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Owl-NtjqrUgTDO_rnzwL-9QQMZTObRSTdC3oIQ7EbSynkAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Owl-NtjqrUgTDO_rnzwL-9QQMZTObRSTdC3oIQ7EbSynkAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241122A05XBC00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241122A05XBC00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["WTO","BK4145","BK1209","BK1593","02135"],"gpt_icon":0},{"id":"2485728262","title":"昊海生物科技(06826)下跌5.12%，报26.85元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485728262","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485728262?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:23","pubTimestamp":1732260238,"startTime":"0","endTime":"0","summary":"11月22日，昊海生物科技盘中下跌5.12%，截至15:23，报26.85元/股，成交894.31万元。上海昊海生物科技股份有限公司是一家专注于研发、生产及销售医用生物材料的高科技生物医药企业，主要产品包括人工晶状体系列、眼视光终端产品系列、医用透明质酸/玻璃酸钠系列等，其中在全球人工晶状体生产商中排名第七。截至2024年三季报，昊海生物科技营业总收入20.75亿元、净利润3.41亿元。11月21日，公司以每股28.4-28.55港元回购1.1万股,回购金额31.32万港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/22152345572230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1593","06826"],"gpt_icon":0},{"id":"2485827172","title":"昊海生物科技盘中异动 大幅下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485827172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485827172?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:23","pubTimestamp":1732260234,"startTime":"0","endTime":"0","summary":"2024年11月22日下午盘15时23分，昊海生物科技股票出现波动，股价快速下挫5.12%。截至发稿，该股报26.850港元/股，成交量32.544万股，换手率0.81%，振幅5.30%。昊海生物科技股票所在的医疗设备及用品行业中，整体跌幅为0.26%。其相关个股中，华检医疗、加和国际控股、GUANZE MEDICAL涨幅较大，振幅较大的相关个股有微创机器人-B、心通医疗-B、润迈德-B，振幅分别为12.13%、8.70%、7.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122152355abd6b40f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122152355abd6b40f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","06826"],"gpt_icon":0},{"id":"2485289002","title":"复锐医疗科技盘中异动 下午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485289002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485289002?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:59","pubTimestamp":1732258795,"startTime":"0","endTime":"0","summary":"2024年11月22日下午盘14时59分，复锐医疗科技股票出现异动，股价急速下挫5.06%。截至发稿，该股报3.190港元/股，成交量18.84万股，换手率0.04%，振幅4.46%。复锐医疗科技股票所在的医疗设备及用品行业中，整体跌幅为0.26%。复锐医疗科技公司简介：SISRAM医疗有限公司是一家主要从事于设计、开发、制造及销售能量美容医学及微创医疗美容治疗系统的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145955abd6a52b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145955abd6a52b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1100","BK1585","01696"],"gpt_icon":0},{"id":"2485719283","title":"四环医药盘中异动 下午盘大幅跳水5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485719283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485719283?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:09","pubTimestamp":1732255754,"startTime":"0","endTime":"0","summary":"2024年11月22日下午盘14时09分，四环医药股票出现波动，股价大幅下挫5.71%。截至发稿，该股报0.660港元/股，成交量1115万股，换手率0.12%，振幅7.14%。四环医药股票所在的药品行业中，整体跌幅为0.22%。其相关个股中，三爱健康集团、中智药业、天大药业涨幅较大，振幅较大的相关个股有中生联合、德琪医药-B、君圣泰医药-B，振幅分别为12.31%、10.14%、9.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122140914abd68a43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122140914abd68a43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","BK1600","00460","BK1191"],"gpt_icon":0},{"id":"2485285359","title":"四环医药(00460)下跌5.71%，报0.66元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485285359","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485285359?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:09","pubTimestamp":1732255754,"startTime":"0","endTime":"0","summary":"11月22日，四环医药(00460)盘中下跌5.71%，截至14:09，报0.66元/股，成交760.82万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业，主要业务为生产和销售心脑血管处方药物，自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2024年中报，四环医药营业总收入9.5亿元、净利润-3342.4万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/22140945567946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00460","BK1600","BK1593","BK1191","BK1515"],"gpt_icon":0},{"id":"2485406046","title":"医思健康盘中异动 早盘股价大涨5.71%报0.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485406046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485406046?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:26","pubTimestamp":1732245982,"startTime":"0","endTime":"0","summary":"2024年11月22日早盘11时26分，医思健康股票出现波动，股价大幅上涨5.71%。截至发稿，该股报0.740港元/股，成交量97.3万股，换手率0.08%，振幅10.00%。资金方面，该股资金流入36.444万港元，流出27.742万港元。医思健康股票所在的医疗及医学美容服务行业中，整体涨幅为0.22%。其相关个股中，德斯控股、REPUBLIC HC、熙康云医院涨幅较大，振幅较大的相关个股有REPUBLIC HC、德斯控股、梅斯健康，振幅分别为49.53%、30.77%、15.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122112622971a803d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122112622971a803d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1215","BK1593","BK1511","02138"],"gpt_icon":0},{"id":"2485847794","title":"现代牙科收购Hexa Ceram74%股份 交易额达9.39亿泰铢","url":"https://stock-news.laohu8.com/highlight/detail?id=2485847794","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485847794?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:46","pubTimestamp":1732240005,"startTime":"0","endTime":"0","summary":"财中社11月22日电现代牙科（03600）发布公告，宣布与卖方A和卖方B签订了两项买卖协议，涉及收购HexaCeram74%的股份。根据买卖协议A，买方有条件同意购买占目标公司已注册资本25%的股份，总代价为3.26亿泰铢（约7438万港元）；而在买卖协议B中，买方有条件同意购买占目标公司已注册资本49%的股份，总代价为6.13亿泰铢（约1.4亿港元）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411223247669542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03600","BK1593","BK1583","BK1100"],"gpt_icon":0},{"id":"2485478639","title":"现代牙科拟收购泰国牙科实验室Hexa Ceram74%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485478639","media":"新浪港股","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485478639?lang=zh_cn&edition=full","pubTime":"2024-11-22 07:47","pubTimestamp":1732232820,"startTime":"0","endTime":"0","summary":"　　现代牙科公布，于2024年11月21日，公司的间接全资附属Modern Dental Asia Pacific Limited拟向Acheval Holdings Limited、Hexa Europe B.V．分别收购Hexa Ceram Company Limited已注册资本的25%及49%，代价分别约为约7438.4万港元、1.4亿港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvuu0778473.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvuu0778473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","03600","BK1100","BK1593"],"gpt_icon":0},{"id":"2485347814","title":"智通港股早知道 | 华虹(01347)获意法半导体公司40nm MCU订单 恒生指数公司今天宣布第三季度检讨结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2485347814","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485347814?lang=zh_cn&edition=full","pubTime":"2024-11-22 07:39","pubTimestamp":1732232377,"startTime":"0","endTime":"0","summary":"为了支持这一目标的实现，意法半导体首席执行官Jean-Marc Chery于当地时间周三宣布，将与中国第二大晶圆代工厂华虹集团合作，计划在2025年底在中国本土生产40nm MCU，其认为在中国进行本地制造对其竞争地位至关重要。意法半导体制造主管 Fabio Gualandris 表示，在中国生产的其他原因包括当地供应链的成本效益、兼容性问题以及政府限制的风险。恒生指数公司将宣布第三季度检讨结果。预计华润三九将使用出售华润圣火 51%权益的所得款项补充其营运资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BMPRXN33.USD","BK1539","BK1589","HHImain","BK4141","LU0708995583.HKD","BK1583","BK4585","IE0034224299.USD","BK1100","BK4588","BK1593","82333","HSI","LU0052750758.USD","02423","MCHmain","01347","LU2476274308.USD","STM","02333","HSCEI","02833","LU2778985437.USD","BK1119","513600","GWLLY","YANG","LU0320764599.SGD","601633","SG9999006597.SGD","IE00BMPRXR70.SGD","BK4554","BK1607","03600","BK1097","BK1163","HSTECH"],"gpt_icon":1},{"id":"2485446301","title":"现代牙科(03600.HK)斥资逾2亿元收购  进军泰国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446301","media":"阿斯达克财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446301?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:29","pubTimestamp":1732213740,"startTime":"0","endTime":"0","summary":"现代牙科(03600.HK) 公布，向两名独立第三方收购泰国义齿及牙科设备业务-Hexa Ceram合共74%股权，以实现业务区域多元化，总代价9.39亿泰铢(约2.14亿港元)。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230602112150274_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230602112150274_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1398623/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03600","BK1583","BK1100","BK1593"],"gpt_icon":0},{"id":"2485964774","title":"现代牙科拟收购Hexa Ceram Company74%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2485964774","media":"格隆汇","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485964774?lang=zh_cn&edition=full","pubTime":"2024-11-21 21:26","pubTimestamp":1732195606,"startTime":"0","endTime":"0","summary":"在上述团的愿景及业务策略的引导下，董事会认为该等收购事项可让集团进入泰国市场，而集团目前在此市场中并无显著的业务规模。具体而言，该等收购事项将使本集团整合在泰国设立的销售及分销网络，从而获得目标公司广泛的客户基础，让集团能够进一步扩大及补充其产品组合、分销及销售网络。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121212646a24b5587&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121212646a24b5587&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1593","03600","BK1583"],"gpt_icon":0},{"id":"2485249666","title":"现代牙科(03600)拟收购泰国牙科实验室Hexa Ceram74%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485249666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485249666?lang=zh_cn&edition=full","pubTime":"2024-11-21 21:24","pubTimestamp":1732195460,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科 公布，于2024年11月21日，公司的间接全资附属Modern Dental Asia Pacific Limited拟向Acheval Holdings Limited、Hexa Europe B.V.分别收购Hexa Ceram Company Limited已注册资本的25%及49%，代价分别约为约7438.4万港元、1.4亿港元。董事会认为该等收购事项可让集团进入泰国市场，而该集团目前在此市场中并无显著的业务规模。认沽期权及认购期权均可让集团在规定的禁售期届满后，按照经公平磋商后预先协定的期权价格，收购目标公司的全部股份，从而让集团享有对目标公司的全面控制权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03600","BK1583","BK1593","BK1100"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"undefined(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供undefined(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":",BK1593,股票,股票老虎,股票老虎国际,行情,股票行情,股价,股市,股票价格,股票交易,股票购买,股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"undefined(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供undefined(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}